High Throughput Screening and Development of Antiviral compound against Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 남태규 | - |
dc.date.accessioned | 2021-06-22T12:26:18Z | - |
dc.date.available | 2021-06-22T12:26:18Z | - |
dc.date.issued | 2018-06-12 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/7254 | - |
dc.title | High Throughput Screening and Development of Antiviral compound against Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) | - |
dc.type | Conference | - |
dc.citation.conferenceName | International Conference on Antiviral Research | - |
dc.citation.conferencePlace | Porto, Portugal | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.